HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting

Stock News

11/05

LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts had been selected for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH). The company shared further details about its investigational drugs, LBL-034 and LBL-076, with multiple research abstracts accepted by the ASH conference. Notably, one clinical study on LBL-034 was chosen as the first oral presentation on the opening day, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1116382406"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1116382406\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1116382406?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 11:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116382406","market":"nz","top_or_hot":-1,"title":"HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting","media":"Stock News","content":"<p>LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts had been selected for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH). The company shared further details about its investigational drugs, LBL-034 and LBL-076, with multiple research abstracts accepted by the ASH conference. Notably, one clinical study on LBL-034 was chosen as the first oral presentation on the opening day, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-05 11:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts had been selected for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH). The company shared further details about its investigational drugs, LBL-034 and LBL-076, with multiple research abstracts accepted by the ASH conference. Notably, one clinical study on LBL-034 was chosen as the first oral presentation on the opening day, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ASH","symbol_name":"Ashland","start_time":0,"source_url":"","article_id":"1116382406","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116382406","pubTimestamp":1762313292,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ASH":"Ashland","BK1161":"生物科技","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","09887":"维立志博-B","BK4109":"特种化学制品"},"translate_title":"港股动向|利德生物-B(09887)涨超3%，五项血液学研究成果亮相2025年ASH年会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1,"ASH":1},"content_text":"LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts had been selected for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH). The company shared further details about its investigational drugs, LBL-034 and LBL-076, with multiple research abstracts accepted by the ASH conference. Notably, one clinical study on LBL-034 was chosen as the first oral presentation on the opening day, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}